1. Home
  2. CLB vs SGHT Comparison

CLB vs SGHT Comparison

Compare CLB & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core Laboratories Inc.

CLB

Core Laboratories Inc.

SELL

Current Price

$10.01

Market Cap

502.0M

Sector

N/A

ML Signal

SELL

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

SELL

Current Price

$8.30

Market Cap

489.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CLB
SGHT
Founded
1936
2011
Country
United States
United States
Employees
3300
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
502.0M
489.7M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
CLB
SGHT
Price
$10.01
$8.30
Analyst Decision
Buy
Buy
Analyst Count
3
8
Target Price
★ $15.00
$10.17
AVG Volume (30 Days)
★ 630.2K
337.0K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 0.41%
N/A
EPS Growth
N/A
★ 28.16
EPS
★ 0.11
N/A
Revenue
★ $526,520,000.00
$77,363,000.00
Revenue This Year
N/A
$16.75
Revenue Next Year
$2.52
$11.78
P/E Ratio
$88.91
★ N/A
Revenue Growth
★ 0.51
N/A
52 Week Low
$9.48
$3.38
52 Week High
$20.36
$9.71

Technical Indicators

Market Signals
Indicator
CLB
SGHT
Relative Strength Index (RSI) 38.27 47.74
Support Level $9.72 $7.77
Resistance Level $10.74 $8.82
Average True Range (ATR) 0.34 0.50
MACD 0.04 -0.09
Stochastic Oscillator 40.48 27.77

Price Performance

Historical Comparison
CLB
SGHT

About CLB Core Laboratories Inc.

Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: